These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3038697)

  • 1. Induction of v-mos and activated Ha-ras oncogene expression in quiescent NIH 3T3 cells causes intracellular alkalinisation and cell-cycle progression.
    Doppler W; Jaggi R; Groner B
    Gene; 1987; 54(1):147-53. PubMed ID: 3038697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenes modulate cellular gene expression and repress glucocorticoid regulated gene transcription.
    Jaggi R; Friis R; Groner B
    J Steroid Biochem; 1988 May; 29(5):457-63. PubMed ID: 3379954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization of the Ca2+-mobilizing system to serum growth factors by Ha-ras and v-mos.
    Maly K; Doppler W; Oberhuber H; Meusburger H; Hofmann J; Jaggi R; Grunicke HH
    Mol Cell Biol; 1988 Oct; 8(10):4212-6. PubMed ID: 3141785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells.
    Cai H; Szeberényi J; Cooper GM
    Mol Cell Biol; 1990 Oct; 10(10):5314-23. PubMed ID: 2118993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Ha-ras on phosphatidylinositol metabolism, Na+/H+-antiporter and mobilization of intracellular calcium.
    Maly K; Oberhuber H; Doppler W; Hoflacher J; Jaggi R; Groner B; Grunicke H
    Adv Enzyme Regul; 1988; 27():121-31. PubMed ID: 2854946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The v-mos and c-Ha-ras oncoproteins exert similar effects on the pattern of protein synthesis.
    Klemenz R; Hoffmann S; Jaggi R; Werenskiold AK
    Oncogene; 1989 Jun; 4(6):799-803. PubMed ID: 2525241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR.
    Jaggi R; Salmons B; Muellener D; Groner B
    EMBO J; 1986 Oct; 5(10):2609-16. PubMed ID: 3023051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of RI alpha subunit of cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 proto-oncogenes.
    Ciardiello F; Pepe S; Bianco C; Baldassarre G; Ruggiero A; Bianco C; Selvam MP; Bianco AR; Tortora G
    Int J Cancer; 1993 Feb; 53(3):438-43. PubMed ID: 8094073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microinjection of ras p21 induces a rapid rise in intracellular pH.
    Hagag N; Lacal JC; Graber M; Aaronson S; Viola MV
    Mol Cell Biol; 1987 May; 7(5):1984-8. PubMed ID: 3037340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism and biological significance of the Ha-ras-induced activation of the Na+/H(+)-antiporter.
    Maly K; Hochleitner B; Uberall F; Loferer H; Oberhuber H; Doppler W; Grunicke H
    Adv Enzyme Regul; 1990; 30():63-74. PubMed ID: 2169700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that the time of entry into S is determined by events occurring in early G1.
    Cosenza SC; Owen TA; Soprano DR; Soprano KJ
    J Biol Chem; 1988 Sep; 263(25):12751-8. PubMed ID: 3137230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters.
    Schönthal A; Herrlich P; Rahmsdorf HJ; Ponta H
    Cell; 1988 Jul; 54(3):325-34. PubMed ID: 2840203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene.
    Dartsch PC; Ritter M; Häussinger D; Lang F
    Eur J Cell Biol; 1994 Apr; 63(2):316-25. PubMed ID: 8082656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid signalling pathways in normal and ras-transfected NIH/3T3 cells.
    Matyas GR; Fishman PH
    Cell Signal; 1989; 1(4):395-404. PubMed ID: 2561989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mos-induced inhibition of glucocorticoid receptor function is mediated by Fos.
    Touray M; Ryan F; Saurer S; Martin F; Jaggi R
    Oncogene; 1991 Feb; 6(2):211-7. PubMed ID: 1847998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of Ha-ras oncogene p21 expression and cell cycle progression in the human colonic cancer cell line HT-29.
    Czerniak B; Herz F; Wersto RP; Koss LG
    Cancer Res; 1987 Jun; 47(11):2826-30. PubMed ID: 3105868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different promoter elements are required for the induced expression of c-fos and c-jun proto-oncogenes by the v-mos oncogene product.
    Schönthal A; Feramisco JR
    New Biol; 1990 Feb; 2(2):143-50. PubMed ID: 2150599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain.
    Binétruy B; Smeal T; Karin M
    Nature; 1991 May; 351(6322):122-7. PubMed ID: 1903181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.